Genespire
Pre-clinicalBuilding the Next Generation of Gene Therapieswith Immune-Shielded Lentiviral Vectors
Founded
2019
Focus
RNA & Gene Therapy
About
Building the Next Generation of Gene Therapieswith Immune-Shielded Lentiviral Vectors
Funding History
2Total raised: $23.5M
Series A$20MSofinnova PartnersJun 15, 2020
Seed$3.5MBiovelocITAJun 15, 2018
Company Info
TypePrivate
Founded2019
LocationMilan, Italy
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile